Aug 28, 2008
Amgen To Discontinue Discounts On Anemia Drug: Report
Amgen Inc is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product's safety, the New York Times said.
Read full story from The Post Chronicle
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Seeking Clinical Research Associate - Oncology (from Feb '07) | 14 hr | Danielle Pic... | 12 |
| Chesapeake Woman Gets Cancer Treatment | 16 hr | gooneygoogoo | 7 |
| Patients Treat Serious Illness As Laughing Matter | Sun | Gail Perry | 2 |
| Goodbye to Crickett | Sat | Carole Trone... | 6 |
| Combined Technologies Facilitate The Rapid Disc... | Nov 27 | choi | 1 |
| December is Cancer-Related Fatigue Awareness Month | Nov 26 | 3yearsNED | 1 |
| Selfless souls donate cadavers so future doctor... | Nov 26 | How to Donate | 1 |
Capricorn
Most Popular